Reviving M&A in Healthcare

This chapter examines the resurgence of mergers and acquisitions in the healthcare and life sciences sectors, driven by innovation and optimism from the J.P. Morgan Conference. It also discusses the transformative impact of artificial intelligence on deal-making and diagnostics, highlighting contrasting valuation perspectives between corporate entities and private equity firms.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.